Cobicistat, elvitegravir, emtricitabine, and tenofovir and Vaqta Pediatric

• Generic Name: cobicistat / elvitegravir / emtricitabine / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: Genvoya, Stribild

Cobicistat reduces the action of enzymes in your liver that break down certain antiviral medicines. This allows the antiviral medicines to be used more safely and effectively at lower doses.

Elvitegravir, emtricitabine and tenofovir are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. HIV can cause acquired immunodeficiency syndrome (AIDS).

Cobicistat, elvitegravir, emtricitabine, and tenofovir is a combination medicine used to treat HIV in adults and children who are at least 12 years old and who weigh at least 55 pounds (25 kilograms). cobicistat, elvitegravir, emtricitabine, and tenofovir is not a cure for HIV or AIDS.

Cobicistat, elvitegravir, emtricitabine, and tenofovir may also be used for purposes not listed in this medication guide.

• Generic Name: hepatitis a pediatric vaccine
• Dosage Forms: n.a.
• Other Brand Names: Havrix Pediatric, Vaqta Pediatric

Hepatitis is a serious disease caused by a virus. Hepatitis causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death.

Hepatitis A is spread through contact with the stool (bowel movements) of a person infected with the hepatitis A virus. This usually occurs by eating food or drinking water that has become contaminated as a result of handling by an infected person.

The Vaqta Pediatric is used to help prevent this disease in children.

This vaccine works by exposing your child to a small amount of the virus, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

Vaccination with Vaqta Pediatric is recommended for all children who are 12 months of age or older. This vaccine is also recommended in children who travel to certain areas of the world where hepatitis A is a common disease.

Other risk factors for hepatitis in children include: receiving treatment for hemophilia or other bleeding disorders, or being in an area where there has been an outbreak of hepatitis A.

Like any vaccine, the Vaqta Pediatric may not provide protection from disease in every person.